1. Home
  2. UMH vs ORIC Comparison

UMH vs ORIC Comparison

Compare UMH & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UMH Properties Inc.

UMH

UMH Properties Inc.

N/A

Current Price

$16.08

Market Cap

1.3B

Sector

Real Estate

ML Signal

N/A

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

N/A

Current Price

$13.18

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UMH
ORIC
Founded
1968
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
UMH
ORIC
Price
$16.08
$13.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
13
Target Price
$17.75
$19.73
AVG Volume (30 Days)
753.2K
1.1M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
5.84%
N/A
EPS Growth
133.33
19.67
EPS
0.08
N/A
Revenue
$261,754,000.00
N/A
Revenue This Year
$5.51
N/A
Revenue Next Year
$2.51
N/A
P/E Ratio
$200.75
N/A
Revenue Growth
8.81
N/A
52 Week Low
$13.93
$7.23
52 Week High
$16.77
$14.93

Technical Indicators

Market Signals
Indicator
UMH
ORIC
Relative Strength Index (RSI) 48.21 49.87
Support Level $14.81 $10.17
Resistance Level $16.28 $14.27
Average True Range (ATR) 0.27 0.63
MACD -0.08 -0.23
Stochastic Oscillator 6.62 14.80

Price Performance

Historical Comparison
UMH
ORIC

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries, is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents. The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, it sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for its sites and homes, where the company is the lessor.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: